and Canada, or 77 internationally, passcode: 7895081 or via live webcast on the company's website at The company suggests participants dial in approximately 10 minutes before the call.Ī replay of the call may be accessed online at or, from approximately 10:30 a.m. The conference call can be accessed by dialing 88 within the U.S. Quest Diagnostics will hold its quarterly conference call to discuss financial results beginning at 8:30 a.m. The additional tables attached below include reconciliations of non-GAAP adjusted measures to GAAP measures. We believe that these non-GAAP measures are useful to investors and analysts to evaluate our performance period over period and relative to competitors, as well as to analyze the underlying trends in our business and to assess our performance. Management may use these non-GAAP measures to evaluate our performance period over period and relative to competitors, to analyze the underlying trends in our business, to establish operational budgets and forecasts and for incentive compensation purposes. Non-GAAP adjusted measures should not be considered as an alternative to the corresponding measures determined under GAAP. Non-GAAP adjusted measures are presented because management believes those measures are useful adjuncts to GAAP results. The term "adjusted" refers to non-GAAP operating performance measures that exclude special items such as restructuring and integration charges, certain financial impacts resulting from the COVID-19 pandemic, amortization expense, excess tax benefits ("ETB") associated with stock-based compensation, costs associated with donations, contributions, and other financial support through Quest for Health Equity, the company's initiative with the Quest Diagnostics Foundation to reduce health disparities in underserved communities, a gain on sale of an ownership interest in a joint venture, and other items. Net income attributable to Quest DiagnosticsĪs used in this press release the term "reported" refers to measures under accounting principles generally accepted in the United States ("GAAP"). Operating income as a percentage of net revenues Net income attributable to Quest Diagnostics (a) Operating income as a percentage of net revenues (a) Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.(dollars in millions, except per share data) The company also provides risk assessment services for the life insurance industry and healthcare organizations and clinicians robust information technology solutions. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally.
0 kommentar(er)
